Jinling Pharmaceutical Company Limited (SHE:000919)
China
· Delayed Price · Currency is CNY 6.95
-0.02 (-0.29%)
Jul 4, 2025, 2:45 PM CST
SHE:000919 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '25 Jul 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 4,335 | 4,104 | 4,023 | 3,966 | 3,856 | 3,876 | Upgrade
| |
Market Cap Growth | 19.16% | 2.02% | 1.43% | 2.86% | -0.52% | 5.34% | Upgrade
|
Enterprise Value | 2,983 | 2,644 | 3,503 | 3,076 | 3,156 | 2,918 | Upgrade
|
Last Close Price | 6.95 | 6.58 | 7.76 | 7.56 | 7.34 | 7.27 | Upgrade
|
PE Ratio | 235.75 | 101.56 | 37.88 | 37.67 | 31.96 | 59.50 | Upgrade
|
Forward PE | - | 20.24 | 20.24 | 20.24 | 20.24 | 20.24 | Upgrade
|
PS Ratio | 1.34 | 1.25 | 1.26 | 1.49 | 1.37 | 1.55 | Upgrade
|
PB Ratio | 0.89 | 0.85 | 0.91 | 1.09 | 1.09 | 1.13 | Upgrade
|
P/TBV Ratio | 1.26 | 1.21 | 1.47 | 1.46 | 1.39 | 1.47 | Upgrade
|
P/FCF Ratio | - | - | - | - | 29.83 | 193.24 | Upgrade
|
P/OCF Ratio | 24.24 | 26.62 | 18.97 | 15.22 | 13.20 | 12.44 | Upgrade
|
PEG Ratio | - | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | Upgrade
|
EV/Sales Ratio | 0.92 | 0.81 | 1.10 | 1.15 | 1.12 | 1.17 | Upgrade
|
EV/EBITDA Ratio | 22.41 | 15.62 | 15.24 | 17.72 | 10.84 | 9.94 | Upgrade
|
EV/EBIT Ratio | - | 104.48 | 43.33 | 60.28 | 18.65 | 16.80 | Upgrade
|
EV/FCF Ratio | -63.32 | - | - | - | 24.42 | 145.51 | Upgrade
|
Debt / Equity Ratio | 0.04 | 0.04 | 0.01 | 0.00 | 0.01 | - | Upgrade
|
Debt / EBITDA Ratio | 1.42 | 1.08 | 0.18 | 0.03 | 0.06 | - | Upgrade
|
Debt / FCF Ratio | - | - | - | - | 0.13 | - | Upgrade
|
Asset Turnover | 0.57 | 0.57 | 0.64 | 0.59 | 0.64 | 0.59 | Upgrade
|
Inventory Turnover | 10.60 | 9.52 | 9.45 | 8.64 | 9.46 | 8.64 | Upgrade
|
Quick Ratio | 3.50 | 3.25 | 2.69 | 2.72 | 2.37 | 2.27 | Upgrade
|
Current Ratio | 3.78 | 3.52 | 2.98 | 3.04 | 2.67 | 2.56 | Upgrade
|
Return on Equity (ROE) | -0.17% | 0.39% | 3.20% | 3.18% | 4.39% | 2.73% | Upgrade
|
Return on Assets (ROA) | -0.17% | 0.27% | 1.01% | 0.71% | 2.42% | 2.57% | Upgrade
|
Return on Capital (ROIC) | -0.21% | 0.33% | 1.25% | 0.89% | 3.03% | 3.17% | Upgrade
|
Return on Capital Employed (ROCE) | - | 0.50% | 1.80% | 1.40% | 4.70% | 5.00% | Upgrade
|
Earnings Yield | 0.42% | 0.98% | 2.64% | 2.66% | 3.13% | 1.68% | Upgrade
|
FCF Yield | -1.09% | -1.16% | -0.64% | -1.24% | 3.35% | 0.52% | Upgrade
|
Dividend Yield | 1.44% | 1.52% | 1.29% | 1.32% | 1.36% | 1.38% | Upgrade
|
Payout Ratio | 346.09% | 156.50% | 48.17% | 48.60% | 42.00% | 138.60% | Upgrade
|
Buyback Yield / Dilution | -22.40% | -17.56% | -0.01% | 0.02% | 0.01% | -0.02% | Upgrade
|
Total Shareholder Return | -20.96% | -16.04% | 1.28% | 1.34% | 1.38% | 1.36% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.